title: Enhanced expression from the human cytomegalovirus immediate-early promoter in a non-replicating adenovirus encoded reporter gene following cellular exposure to chemical DNA damaging agents.
abstract: We have examined expression from the human cytomegalovirus (CMV) promoter of a reporter gene encoded in a replication-deficient adenovirus following cellular exposure to heat shock and chemical DNA damaging agents. Expression of the reporter gene was enhanced following prior treatment of cells with cisplatin and N-acetoxy-acetylaminofluorine, but not heat shock. This enhancement was more pronounced and induced by lower chemical concentrations in xeroderma pigmentosum (XP) and Cockayne syndrome fibroblasts that are deficient in the transcription-coupled repair (TCR) pathway of nucleotide excision repair (NER) compared to that in TCR-proficient XP-C and normal strains. This is consistent with an induction of expression from the CMV promoter mediated by persistent (unrepaired) DNA damage in active genes. We show also that expression of the CMV-driven reporter is enhanced following treatment of several human tumour cell lines. This later finding has implications for combined chemotherapy and gene therapy using CMV-driven expression vectors.
authors.affiliation: Department of Biology, McMaster University, Hamilton, Ont., Canada L8S 4K1.
authors.forename: Natalie J
authors.initials: NJ
authors.lastname: Zacal
authors.forename: Murray A
authors.initials: MA
authors.lastname: Francis
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Rainbow
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D002478:Cells, Cultured; D003587:Cytomegalovirus / Q000235:genetics*; D004247:DNA / Q000187:drug effects / Q000235:genetics*; D004249:DNA Damage / Q000235:genetics*; D004260:DNA Repair / Q000235:genetics; D005347:Fibroblasts / Q000187:drug effects / Q000502:physiology; D015967:Gene Expression Regulation, Viral / Q000187:drug effects / Q000235:genetics; D024861:Genetic Enhancement / Q000379:methods*; D006801:Humans; D009153:Mutagens / Q000008:administration & dosage; D009369:Neoplasms / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics; D014162:Transfection / Q000379:methods; D014779:Virus Replication / Q000187:drug effects / Q000235:genetics
chemical_list: D009153:Mutagens; D004247:DNA